Literature DB >> 11160300

Lupus-specific antiribonucleoprotein B cell tolerance in nonautoimmune mice is maintained by differentiation to B-1 and governed by B cell receptor signaling thresholds.

Y Qian1, C Santiago, M Borrero, T F Tedder, S H Clarke.   

Abstract

Systemic lupus erythematosus is an autoimmune disease characterized by the presence of autoantibodies. One of the unique targets of the immune system in systemic lupus erythematosus is Sm, a ribonucleoprotein present in all cells. To understand the regulation of B cells specific to the Sm Ag in normal mice, we have generated an Ig H chain transgenic mouse (2-12H Tg). 2-12H Tg mice produce B cells specific for the Sm that remain tolerant due to ignorance. We demonstrate here that anti-Sm B cells of 2-12H Tg mice can differentiate into Sm-specific peritoneal B-1 cells that remain tolerant. Differentiation to B-1 and tolerance are governed by the strength of B cell receptor signaling, since manipulations of the B cell receptor coreceptors CD19 and CD22 affect anti-Sm B cell differentiation and autoantibody production. These results suggest a differentiation scheme in which peripheral ignorance to Sm is maintained in mice by the differentiation of anti-Sm B cells to B-1 cells that have increased activation thresholds.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160300     DOI: 10.4049/jimmunol.166.4.2412

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Early preplasma cells define a tolerance checkpoint for autoreactive B cells.

Authors:  Donna A Culton; Brian P O'Conner; Kara L Conway; Ramiro Diz; Jennifer Rutan; Barbara J Vilen; Stephen H Clarke
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

Review 2.  Understanding B-cell tolerance through the use of immunoglobulin transgenic models.

Authors:  Kirthi Raman Kumar; Chandra Mohan
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 3.  Autoreactive B cells and epigenetics.

Authors:  Yves Renaudineau; Soizic Garaud; Christelle Le Dantec; Ruby Alonso-Ramirez; Capucine Daridon; Pierre Youinou
Journal:  Clin Rev Allergy Immunol       Date:  2010-08       Impact factor: 8.667

Review 4.  Contributions of B cells to lupus pathogenesis.

Authors:  Allison Sang; Ying-Yi Zheng; Laurence Morel
Journal:  Mol Immunol       Date:  2013-12-12       Impact factor: 4.407

5.  Similar CD19 dysregulation in two autoantibody-associated autoimmune diseases suggests a shared mechanism of B-cell tolerance loss.

Authors:  Donna A Culton; Matilda W Nicholas; Donna O Bunch; Quan Li Zhen; Thomas B Kepler; Mary Anne Dooley; Chandra Mohan; Patrick H Nachman; Stephen H Clarke
Journal:  J Clin Immunol       Date:  2006-12-29       Impact factor: 8.317

6.  Development of autoimmune hepatitis-like disease and production of autoantibodies to nuclear antigens in mice lacking B and T lymphocyte attenuator.

Authors:  Yoshihiro Oya; Norihiko Watanabe; Takayoshi Owada; Mie Oki; Koichi Hirose; Akira Suto; Shin-Ichiro Kagami; Hiroshi Nakajima; Takashi Kishimoto; Itsuo Iwamoto; Theresa L Murphy; Kenneth M Murphy; Yasushi Saito
Journal:  Arthritis Rheum       Date:  2008-08

7.  The regulation of autoreactive B cells during innate immune responses.

Authors:  Barbara J Vilen; Jennifer A Rutan
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

8.  Anti-Sm B cell tolerance and tolerance loss in systemic lupus erythematosus.

Authors:  Stephen H Clarke
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 9.  Human B-1 cells take the stage.

Authors:  Thomas L Rothstein; Daniel O Griffin; Nichol E Holodick; Tam D Quach; Hiroaki Kaku
Journal:  Ann N Y Acad Sci       Date:  2013-05       Impact factor: 5.691

Review 10.  Immunological cells and functions in Gaucher disease.

Authors:  Manoj Kumar Pandey; Gregory A Grabowski
Journal:  Crit Rev Oncog       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.